Interestingly, the above-described inhibition of galectin-3 binding was shown to occur specifically in the presence of α2,6- and not α2,3-sialylated oligosaccharides [39], which further emphasizes the importance of linkage-specific examination of sialylated glycoforms in cancer tissues. Here, LGALS3 is linked to cancer.